Concepedia

Malcolm C. Carter

MC

Statistics

Publications

4

Citations

547

H-Index

4

Active since

2001

Affiliations

National Institutes of Health(Current)

Malcolm C. Carter is an author at National Institutes of Health specializing in drug discovery, medicine, and pharmacology.

Top concepts

Publications per year

2001–2007

4

Publications

4

The characterization of novel, dual ErbB-2/EGFR, tyrosine kinase inhibitors: potential therapy for cancer.

David W. Rusnak, Karen Affleck, Stuart Cockerill et al. · PubMed · 2001 · 297 citations

, , +18

RSV604, a Novel Inhibitor of Respiratory Syncytial Virus Replication

Joanna Chapman, Elizabeth Abbott, Dagmar Alber et al. · Antimicrobial Agents and Chemotherapy · 2007 · 135 citations · Full text

1,4-Benzodiazepines as Inhibitors of Respiratory Syncytial Virus

Malcolm C. Carter, Dagmar Alber, Robert C. Baxter et al. · Journal of Medicinal Chemistry · 2006 · 63 citations · Full text

1,4-Benzodiazepines as Inhibitors of Respiratory Syncytial Virus. The Identification of a Clinical Candidate

Elisa A. Henderson, Dagmar Alber, Robert C. Baxter et al. · Journal of Medicinal Chemistry · 2007 · 52 citations

, , +12

1–4 of 4